These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 23695074)
1. Outcome of patients with chronic migraine with medication overuse and depression after duloxetine: influence of coexisting obsessive compulsive disorder. Curone M; Tullo V; Savino M; Proietti-Cecchini A; Bussone G; D'Amico D Neurol Sci; 2013 May; 34 Suppl 1():S175-7. PubMed ID: 23695074 [TBL] [Abstract][Full Text] [Related]
2. Obsessive-compulsive disorder and migraine with medication-overuse headache. Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831 [TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive aspects as predictors of poor response to treatments in patients with chronic migraine and medication overuse. Curone M; D'Amico D; Bussone G Neurol Sci; 2012 May; 33 Suppl 1():S211-3. PubMed ID: 22644206 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and profile of obsessive-compulsive trait in patients with chronic migraine and medication overuse. Curone M; Tullo V; Lovati C; Proietti-Cecchini A; D'Amico D Neurol Sci; 2014 May; 35 Suppl 1():185-7. PubMed ID: 24867863 [TBL] [Abstract][Full Text] [Related]
5. Open-label study of duloxetine for the treatment of obsessive-compulsive disorder. Dougherty DD; Corse AK; Chou T; Duffy A; Arulpragasam AR; Deckersbach T; Jenike MA; Keuthen NJ Int J Neuropsychopharmacol; 2015; 18(2):. PubMed ID: 25637377 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of duloxetine as a migraine preventive medication: possible predictors of response in a retrospective chart review. Taylor AP; Adelman JU; Freeman MC Headache; 2007 Sep; 47(8):1200-3. PubMed ID: 17883526 [TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [TBL] [Abstract][Full Text] [Related]
8. Psychopathological profile of patients with chronic migraine and medication overuse: study and findings in 50 cases. Curone M; Tullo V; Mea E; Proietti-Cecchini A; Peccarisi C; Bussone G Neurol Sci; 2011 May; 32 Suppl 1():S177-9. PubMed ID: 21533740 [TBL] [Abstract][Full Text] [Related]
9. Disability in chronic migraine patients with medication overuse: treatment effects at 1-year follow-up. Grazzi L; Andrasik F; D'Amico D; Usai S; Kass S; Bussone G Headache; 2004; 44(7):678-83. PubMed ID: 15209690 [TBL] [Abstract][Full Text] [Related]
10. Duloxetine prophylaxis for episodic migraine in persons without depression: a prospective study. Young WB; Bradley KC; Anjum MW; Gebeline-Myers C Headache; 2013 Oct; 53(9):1430-7. PubMed ID: 24032526 [TBL] [Abstract][Full Text] [Related]
11. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up. Grazzi L; Sansone E; Raggi A; D'Amico D; De Giorgio A; Leonardi M; De Torres L; Salgado-García F; Andrasik F J Headache Pain; 2017 Dec; 18(1):15. PubMed ID: 28161874 [TBL] [Abstract][Full Text] [Related]
13. An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache. Volpe FM J Clin Psychiatry; 2008 Sep; 69(9):1449-54. PubMed ID: 19193344 [TBL] [Abstract][Full Text] [Related]
14. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial. Engelstoft IMS; Carlsen LN; Munksgaard SB; Nielsen M; Jensen RH; Bendtsen L Eur J Pain; 2019 Jul; 23(6):1162-1170. PubMed ID: 30793412 [TBL] [Abstract][Full Text] [Related]
15. Similarities and differences between chronic migraine and episodic migraine. Ferrari A; Leone S; Vergoni AV; Bertolini A; Sances G; Coccia CP; Ottani A; Pinetti D; Sternieri E Headache; 2007 Jan; 47(1):65-72. PubMed ID: 17355496 [TBL] [Abstract][Full Text] [Related]
16. Disability in chronic migraine with medication overuse: treatment effects through 5 years. Andrasik F; Grazzi L; Usai S; Kass S; Bussone G Cephalalgia; 2010 May; 30(5):610-4. PubMed ID: 19614686 [TBL] [Abstract][Full Text] [Related]
17. Gender differences in obsessive-compulsive disorder traits among chronic migraine patients. Viticchi G; Falsetti L; Salvemini S; Silvestrini M; Riva A; Buratti L; Bartolini M Neurol Sci; 2022 Sep; 43(9):5735-5737. PubMed ID: 35819561 [TBL] [Abstract][Full Text] [Related]
18. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858 [TBL] [Abstract][Full Text] [Related]
19. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire. Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257 [TBL] [Abstract][Full Text] [Related]
20. [Investigation of obsessive-compulsive symptoms in patients with migraine]. Yetkin Özden S; Baykan B; Ertekin E Agri; 2015; 27(1):18-25. PubMed ID: 25867870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]